Feasibility of using determine-TB LAM test in HIV-infected adults in programmatic conditions Mathabire SC1, 2, Cossa L³, Mpunga J⁴ , Manhica I⁵, Amoros.

Slides:



Advertisements
Similar presentations
The Roadmap to Successful Xpert Implementation - 37 steps -
Advertisements

Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Pilot Implementation of Point-Of-Care CD4 Counting in Mozambique’s National Health System Ilesh V. Jani Instituto Nacional de Saúde Maputo, Mozambique.
Transfusion Quiz. Q1. What colour blood tube is used for a group and cross match sample? Red Purple Pink Grey.
Task shifting & HRH Crisis: field experience and current thinking within MSF Mit Philips, Médecins Sans Frontières, Brussels. WHO satelite conference,
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
National TB/ Leprosy Programme Manager
experience from Lesotho
Evaluating Cost Gavin Steel, Jude Nwokike, Mohan P. Joshi & Mupela Ntengu Development and Implementation of a Multi-Method Medication Adherence Assessment.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
1Management Sciences for Health A LABORATORY BASED APPROACH TO REDUCE LOSS TO FOLLOW UP OF HIV POSITIVE CLIENTS.
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
Monitoring and Evaluation Module 12 – March 2010.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Charlie Masiku Deputy Medical Coordinator MSF HIV Project, Chiradzulu, Malawi Capetown 22nd September 2014 Early experience with implementation of SAMBA.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Task Shifting in Malawi around delivery of antiretroviral therapy Anthony D Harries “The Union” Paris, France.
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
Point of Care Testing for MRSA Nigel Brenwald Department of Microbiology Sandwell and West Birmingham Hospitals NHS Trust.
Task-shifting of HIV care and ART initiation: Three year evaluation of a mixed-care provider model for ART delivery Megan McGuire 1, Jihane Ben-Farhat.
Principles and Structure of a Research Protocol Anthony Harries The Union, Paris, France.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
From HIV Testing to Treatment: Operations Research to Improve ARV Treatment Programs Treatment Acceleration Program Meeting November 30, 2006 Mark Micek,
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
INS Point-Of-Care CD4 Improves Patient Retention and Time-To-Initiation for ART in Mozambique Ilesh Jani 1, Nádia Sitoe 1, Eunice Alfai 1, Patrina Chongo.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
Evaluation of SAMBA Viral Load point-of-care test operation by trained non-health workers in rural Health Centers, Chiradzulu District, Malawi Birgit.
CDC and support for Point of Care Testing Accreditation Muthoni Junghae CDC-Kenya LAUNCH OFF POINT OF CARE TESTING ACCREDITATION PROGRAM PANAFRIC HOTEL-18TH.
LOW HCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB-SAHARAN AFRICA
Title of the Change Project
Who is the severely ill HIV+ patient in 2017? Defining advanced HIV
Disclosure of HIV status to children living with HIV in Malawi: needs assessment and formative evaluation of an intervention to help with the disclosure.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
A Way out of Directly Observed Therapy (DOT): Community approaches to Self-Administered Treatment for Rifampicin Resistant Tuberculosis in Khayelitsha,
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
Gaps in the cascade of care in two high prevalence settings in Zimbabwe and Malawi Nolwenn Conan1, Cyrus Paye2, Erica Simons2, Abraham Mapfumo3, Tsitsi.
2Ministry of Health and Child Care, AIDS & TB Unit, Harare, Zimbabwe
Using Detainees and Peer Educators in HIV prevention and systematic TB screening: Kigali Central Prison (PCK) Eugenie INGABIRE.
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
TB- HIV Collaborative activities in Romania- may 2006 status
Participants 18year old+
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
LAM assay: overview and practical guidance on its adoption and use
Research & Evaluation Improving measurement for improvement
Integrated Testing on the GeneXpert
INTRODUCTION OF URINE LF-LAM TEST IN SA
Find and Treat All Missing Persons with TB
Evidence for use of urinary LAM
Mark Lobato, MD Division of TB Elimination
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Extended ART Initiation Criteria Can Be Implemented Successfully in Rural South Africa Sarah Jane Steele1, Gemma Arellano2, Tom Ellman3, Amir Shroufi1,
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
The role of the community in TB control
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Dr AKAKI Angennes; Dr SAN Koffi / NTCP
11 iii. Define management and supervision roles and responsibilities
Using Whole Genome Sequencing Analysis in California
Fabio Scano IUATLD Conference Paris, 2003
TB Screening and Differentiated Service Delivery: State of the Art
Rose Nyirenda Ministry of Health, Malawi
Stakeholder engagement and research utilization: Insights from Namibia
Performance of mPima for quantification of HIV Viral load for pregnant and post-partum woman in primary health care clinics in Mozambique Team: B. Meggi.
GOES fairly fast…with community to say stockouts and activism, hosp to say RAU, PHC to say ambulatory and CD4, then brief tools and HR, then summary. Find.
Presentation transcript:

Feasibility of using determine-TB LAM test in HIV-infected adults in programmatic conditions Mathabire SC1, 2, Cossa L³, Mpunga J⁴ , Manhica I⁵, Amoros Quiles I², Molfino L⁶, Szumilin E⁷, Telnov A8, Huerga H¹ ¹Clinical Research Department Epicentre, Paris France; ²Médecins Sans Frontières, Chiradzulu Malawi; ³Médecins Sans Frontières, Maputo Mozambique; ⁴National TB Control Program Malawi; ⁵National TB Control Program, Mozambique; ⁶Médecins Sans Frontières, Maputo Mozambique; ⁷Médecins Sans Frontières Paris France; ⁸Médecins Sans Frontières, Geneva Switzerland

No conflicts of interest to declare Conflict of Interest No conflicts of interest to declare

Background TB diagnosis is a challenge in resource-limited countries Determine TB- Lipoarabinomannan (LAM): performed on urine results in 25 minutes LAM test accuracy (only HIV-positive): Sensitivity: 4.0 - 66.7% (depending on CD4 count) Specificity: >98% WHO policy guidance (Nov 2015) on LAM test for HIV-positive: Low CD4 count or Severely ill regardless of their CD4 count

Aim To assess the feasibility of using the LAM test in programmatic conditions

Methods Design: Population: HIV-positive adult patients Multi-centric prospective longitudinal studies Malawi and Mozambique 2014 to 2016 Population: HIV-positive adult patients Regardless of TB symptoms : All hospitalized (Malawi) Ambulatory with CD4<100/µl (Mozambique) TB suspects: Ambulatory with CD4 <200 /µl (Malawi and Mozambique)

Methods/ Context Malawi: Chiradzulu District Hospital IPD Hospital OPD 3 PHCs Mozambique: Chamanculo District Centre of Reference Alto-Maé (CRAM) 1 PHC LAM performed in laboratory or consultation rooms

Methods/ Data collection & analysis Mixed methods: Minutes of trainings, interviews of trainees Description of training required before using LAM test Self administered standard questionnaire Assessment of user acceptability of LAM Study electronic databases % agreement between 2 LAM readers , Kappa (95%CI)

Methods/ Data collection & analysis LAM test Turnaround time (TAT) Interval from urine request to clinician getting result Health centre registers, interviews with LAM users Estimate daily workload attributed to LAM test Supervision notes, minutes of meetings, and personal observations Space/ extra equipment required to perform LAM test Strengths and challenges of using LAM

Results/ training Training time: 1.5 hours in Malawi 4 hours in Mozambique. Prior reading of test SOP 20- 30 minutes explanation of LAM Practical *Correct use of reference card challenging Urine loading pad Control window Patient window

Results/space and equipment

Results/LAM ease of use 20/20: test easy or very easy to use 4/20: difficult to distinguish Grade 1 or lighter than Grade 1 No extra space required Test arrived in field with 1 year expiry No need for special storage as it is a small packet Final result … Positive or Negative? 18% Malawi & 8% Mozambique had line fainter than Grade 1

Results/LAM reader agreement Test grade (no line to line Grade 4) 95.2%, kappa=0.91 (95%CI 0.90-0.92) in Malawi 97.2%, kappa=0.95 (95%CI 0.94-0.96) in Mozambique Test interpretation (positive or negative) 98.9%, kappa=0.97 (95%CI 0.96-0.98) in Malawi 98.3%, kappa=0.96 (95%CI 0.95-0.98) in Mozambique

Results/ additional workload Malawi OPD/PHC: 27 minutes (11.3 %) IPD: 66 minutes (25.4 %) Mozambique OPD: 26 minutes (9.5%) *Workload calculation took into account the time used for clinical consultation only Malawi OPD: 27 minutes (11.3 %) (1x27)/(30x8) IPD: 66 minutes (25.4 %) (2x33)/(13x20) Mozambique OPD: 26 minutes (9.5%) (1x26)/(11x25)

Results/ LAM Strengths Rapid results TB treatment on same day Decreased visits before diagnosis → reduced cost for patients Higher proportion of LAM results TAT for LAM Laboratory: 100 - 155 min Bedside: 35 - 44 min TAT for sputum: 2 days TAT chest X-ray: 4 days Malawi lab IPD=140min Malawi lab OPD=92 min Malawi lab PHC= 222min Moza lab CRAM=84 Moza OPD=46

Results/ LAM Challenges Prior CD4 needed to identify LAM eligible patients High demand for CD4 tests (Mozambique) → patients asked to come following day CD4 test result TAT→ 2 hours Test and Treat policy → CD4 tests stopped (Malawi) Urine collection from very sick or unconscious patients Reading card not used prior to study Female patients reluctant to give urine during menses

Conclusions Can be implemented in hospital, PHCs Feasible Easy to perform Results same day Minimal logistics Most submit urine Minimal workload Difficulty discriminate Grade1 line Can be implemented in hospital, PHCs Performed by nurses, clinical officers, doctors Consider task shifting of LAM Partial reliance on CD4 count Retain and prioritize CD4 testing for LAM eligible patients

All staff who participated Acknowledgements NTP Malawi, Mozambique Chiradzulu DHMT Maputo DSCM All staff who participated The patients Maputo DSCM “ direccao saude da cidade de